Abstract
Renal hücreli
karsinom (RHK) teşhisi konulan hastaların üçte biri tanı anında
metastatik evrededir. Erişkin yaş grubunda en sık karşılaşılan
böbrek kanseri olan RHK oldukça yüksek mortalite oranlarına
sahiptir. RHK’nun kemik metastazları çoğunlukla geç dönemde
bulgu vermekle birlikte osteolitik ve agresif seyirlidir. Bu
çalışmada humerus metastazı ile tanı alan 73 yaşındaki RHK
olgusu; kliniği, görüntüleme teknikleri ve uygulanan tedavi
modaliteleri ile birlikte literatür bilgileri ışığında ele
alınmıştır.
References
- Referans 1. Kıroğlu AF, Yuca K, Çankaya H, Bayram İ, Harman M. Alt Dudağa Renal Hücreli Karsinom Metastazı: Olgu Sunumu. Van Med J. 2006;13(1):22-4.
- Referans 2. İzol V, Soyupak B. Metastatik renal hücreli karsinomda cerrahi yaklaşım. Bull Urooncol. 2011:3(9);36-40.
- Referans 3. Shvarts O, Lam JS, Kim HL, Han KR, Figlin R, Belldegrun A. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol. 2004 ;172(3):867-70.
- Referans 4. Demirci İ, Barut AY, Öztürk A, Aybar MD. Kalvaryum Tutulumu ile Ortaya Çıkan Renal Hücreli Karsinom. Turkiye Klinikleri J Nephrol. 2011;6(1):35-8.
- Referans 5. Parkin DM, Bray F, Ferlay J, Pisani P. 2002 Global cancer statistics. CA Cancer J Clin. 2005;55(2):74-108.
- Referans 6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90.
- Referans 7. Toğral G, Arıkan M, Aktaş E, Öztürk R, Oğuz G, Eksioğlu F. Ürolojik malignitelerde kemik metastazlarının cerrahi tedavisi: 70 vaka analizi. Acta Orthop Traumatol Turc. 2015;49(6):634-40.
- Referans 8. Durr HR, Refior HJ. Prognossi of skeletal metastases. Orthopade. 1998; 27(5):294-300.
- Referans 9. Paule B. Interleukin-6 and bone metastasis of renal cancer. Prog Urol. 2001;11(2):368-75.
- Referans 10. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22(14):2942–53.
- Referans 11. Berkiten G, Kumral TL, Yıldırım G, Atar Y, Salturk Z, Dogan MO et al. Metastasis of Renal Cell Carcinoma to the Head and Neck Region. Otolaryngology Online Journal 2016;6(3):133.
- Referans 12. Kulkarni A, Fiorenza F, Grimer RJ, Carter SR, Tillman RM. The results of endoprosthetic replacement for tumours of the distal humerus. J Bone Joint Surg Br. 2003;85(2):240-3.
Abstract
One-third of
patients diagnosed with renal cell carcinoma (RCC) are metastatic at
the time of diagnosis. RCC, the most common kidney cancer in
adulthood, has a very high mortality rate. Bone metastases of the RCC
usually present in the late period. RCC is osteolytic and aggressive.
In this study, a 73-year-old RCC case diagnosed with humerus
metastasis; clinic, imaging techniques and treatment methods are
discussed in the light of literature.
Keywords
References
- Referans 1. Kıroğlu AF, Yuca K, Çankaya H, Bayram İ, Harman M. Alt Dudağa Renal Hücreli Karsinom Metastazı: Olgu Sunumu. Van Med J. 2006;13(1):22-4.
- Referans 2. İzol V, Soyupak B. Metastatik renal hücreli karsinomda cerrahi yaklaşım. Bull Urooncol. 2011:3(9);36-40.
- Referans 3. Shvarts O, Lam JS, Kim HL, Han KR, Figlin R, Belldegrun A. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol. 2004 ;172(3):867-70.
- Referans 4. Demirci İ, Barut AY, Öztürk A, Aybar MD. Kalvaryum Tutulumu ile Ortaya Çıkan Renal Hücreli Karsinom. Turkiye Klinikleri J Nephrol. 2011;6(1):35-8.
- Referans 5. Parkin DM, Bray F, Ferlay J, Pisani P. 2002 Global cancer statistics. CA Cancer J Clin. 2005;55(2):74-108.
- Referans 6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90.
- Referans 7. Toğral G, Arıkan M, Aktaş E, Öztürk R, Oğuz G, Eksioğlu F. Ürolojik malignitelerde kemik metastazlarının cerrahi tedavisi: 70 vaka analizi. Acta Orthop Traumatol Turc. 2015;49(6):634-40.
- Referans 8. Durr HR, Refior HJ. Prognossi of skeletal metastases. Orthopade. 1998; 27(5):294-300.
- Referans 9. Paule B. Interleukin-6 and bone metastasis of renal cancer. Prog Urol. 2001;11(2):368-75.
- Referans 10. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22(14):2942–53.
- Referans 11. Berkiten G, Kumral TL, Yıldırım G, Atar Y, Salturk Z, Dogan MO et al. Metastasis of Renal Cell Carcinoma to the Head and Neck Region. Otolaryngology Online Journal 2016;6(3):133.
- Referans 12. Kulkarni A, Fiorenza F, Grimer RJ, Carter SR, Tillman RM. The results of endoprosthetic replacement for tumours of the distal humerus. J Bone Joint Surg Br. 2003;85(2):240-3.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Case Report |
| Authors | |
| Publication Date | April 1, 2019 |
| Published in Issue | Year 2019 Volume: 2 Issue: 2 |
Cited By
Clinical significance of pretreatment De Ritis ratio in renal cell carcinoma
Journal of Health Sciences and Medicine
https://doi.org/10.32322/jhsm.1451075
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.